Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
作者： A. Uzawa , M. Mori , S. Hayakawa , S. Masuda , S. Kuwabara
DOI: 10.1111/J.1468-1331.2009.02897.X
关键词: Gastroenterology 、 Neuromyelitis optica 、 Statistical analyses 、 Immunology 、 Internal medicine 、 Interferon beta-1b 、 Medicine 、 Multiple sclerosis 、 Treatment period 、 In patient
摘要: Results: The proportion of patients with more than 50% increase in the ARR after IFNB-1b treatment was much higher NMO MS (P = 0.046). significantly lower administration before 0.015), but not NMO. Kaplan–Meier and log-rank statistical analyses revealed that relapse-free rates were 0.032). also showed during pre-IFNB1b period post-IFNB-1b < 0.001), Conclusion: does appear to be effective for preventing relapse likely because differences between immune-pathogenesis MS.
blackwell-synergy.com
researchgate.net 参考文章(14)
L Durelli, B Ferrero, A Oggero, E Verdun, M.R Bongioanni, E Gentile, G.L Isoardo, A Ricci, E Rota, B Bergamasco, M Durazzo, G Saracco, M.A Biava, P.C Brossa, L Giorda, R Pagni, G Aimo, Autoimmune events during interferon beta-1b treatment for multiple sclerosis. Journal of the Neurological Sciences. ,vol. 162, pp. 74- 83 ,(1999) , 10.1016/S0022-510X(98)00299-8
C Papeix, J-S Vidal, J De Seze, C Pierrot-Deseilligny, A Tourbah, B Stankoff, C Lebrun, T Moreau, P Vermersch, B Fontaine, O Lyon-Caen, O Gout, Immunosuppressive therapy is more effective than interferon in neuromyelitis optica Multiple Sclerosis Journal. ,vol. 13, pp. 256- 259 ,(2007) , 10.1177/1352458506070732
T. Takahashi, K. Fujihara, I. Nakashima, T. Misu, I. Miyazawa, M. Nakamura, S. Watanabe, Y. Shiga, C. Kanaoka, J. Fujimori, S. Sato, Y. Itoyama, Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. ,vol. 130, pp. 1235- 1243 ,(2007) , 10.1093/BRAIN/AWM062
T. Saida, K. Tashiro, Y. Itoyama, T. Sato, Y. Ohashi, Z. Zhao, , Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology. ,vol. 64, pp. 621- 630 ,(2005) , 10.1212/01.WNL.0000151856.10387.E2
S. R. Hinson, S. J. Pittock, C. F. Lucchinetti, S. F. Roemer, J. P. Fryer, T. J. Kryzer, V. A. Lennon, Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica Neurology. ,vol. 69, pp. 2221- 2231 ,(2007) , 10.1212/01.WNL.0000289761.64862.CE
V. Wee Yong, S. Chabot, O. Stuve, G. Williams, Interferon beta in the treatment of multiple sclerosis Mechanisms of action Neurology. ,vol. 51, pp. 682- 689 ,(1998) , 10.1212/WNL.51.3.682
Sei Hayakawa, Masahiro Mori, Akiko Okuta, Akiko Kamegawa, Yoshinori Fujiyoshi, Yasumasa Yoshiyama, Kaoru Mitsuoka, Kenichi Ishibashi, Sei Sasaki, Takamichi Hattori, Satoshi Kuwabara, Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. Journal of Neuroimmunology. ,vol. 196, pp. 181- 187 ,(2008) , 10.1016/J.JNEUROIM.2008.03.009
Y. Shimizu, K. Yokoyama, T. Misu, T. Takahashi, K. Fujihara, S. Kikuchi, Y. Itoyama, M. Iwata, Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. Journal of Neurology. ,vol. 255, pp. 305- 307 ,(2008) , 10.1007/S00415-007-0730-5
Dean M Wingerchuk, Vanda A Lennon, Claudia F Lucchinetti, Sean J Pittock, Brian G Weinshenker, The spectrum of neuromyelitis optica Lancet Neurology. ,vol. 6, pp. 805- 815 ,(2007) , 10.1016/S1474-4422(07)70216-8
D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, B. G. Weinshenker, Revised diagnostic criteria for neuromyelitis optica Neurology. ,vol. 66, pp. 1485- 1489 ,(2006) , 10.1212/01.WNL.0000216139.44259.74